X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (96) 96
humans (92) 92
oncology (87) 87
female (78) 78
breast cancer (50) 50
middle aged (47) 47
aged (41) 41
breast neoplasms - drug therapy (39) 39
breast neoplasms - pathology (35) 35
adult (33) 33
cancer (31) 31
prognosis (29) 29
chemotherapy (26) 26
male (25) 25
aged, 80 and over (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
care and treatment (17) 17
hematology, oncology and palliative medicine (17) 17
analysis (16) 16
antineoplastic agents - therapeutic use (16) 16
breast neoplasms - metabolism (16) 16
medicine & public health (15) 15
neoplasm staging (15) 15
survival (15) 15
therapy (15) 15
metastasis (14) 14
doxorubicin (13) 13
health aspects (13) 13
paclitaxel (13) 13
phase-iii trial (13) 13
trastuzumab (13) 13
treatment outcome (13) 13
research (12) 12
women (12) 12
disease-free survival (11) 11
randomized-trial (11) 11
receptor, erbb-2 - metabolism (11) 11
breast neoplasms - surgery (10) 10
neoadjuvant chemotherapy (10) 10
breast neoplasms - mortality (9) 9
cancer patients (9) 9
chemotherapy, adjuvant (9) 9
docetaxel (9) 9
double-blind (9) 9
her2 (9) 9
metastatic breast cancer (9) 9
neoadjuvant therapy (9) 9
retrospective studies (9) 9
tumors (9) 9
1st-line treatment (8) 8
antibodies, monoclonal, humanized (8) 8
biomarkers, tumor - analysis (8) 8
breast neoplasms - therapy (8) 8
neoplasm metastasis (8) 8
open-label (8) 8
paclitaxel - administration & dosage (8) 8
quinazolines - administration & dosage (8) 8
survival analysis (8) 8
anthracyclines (7) 7
breast neoplasms - genetics (7) 7
cancer therapies (7) 7
carcinoma (7) 7
drug therapy (7) 7
estrogen (7) 7
estrogen-receptor (7) 7
follow-up (7) 7
follow-up studies (7) 7
mutation (7) 7
obstetrics & gynecology (7) 7
obstetrics and gynecology (7) 7
patients (7) 7
phase-iii (7) 7
predictive value of tests (7) 7
prospective studies (7) 7
risk factors (7) 7
time factors (7) 7
trial (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
biopsy (6) 6
cyclophosphamide (6) 6
development and progression (6) 6
diagnosis (6) 6
expression (6) 6
genetic aspects (6) 6
internal medicine (6) 6
italy (6) 6
medicine, general & internal (6) 6
melanoma (6) 6
prevention (6) 6
studies (6) 6
surgery (6) 6
surgical adjuvant breast (6) 6
tamoxifen (6) 6
adjuvant chemotherapy (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antibodies, monoclonal - adverse effects (5) 5
bone metastases (5) 5
brain metastases (5) 5
clinical trials (5) 5
clinical trials as topic (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
2012, ISBN 364216482X, Volume 1, 6
Reference
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2010, Volume 122, Issue 1, pp. 181 - 188
Long-term bisphosphonate therapy is associated with increased risk of osteonecrosis of the jaw (ONJ). In a retrospective analysis, a 16% ONJ incidence was... 
Angiogenesis | Bisphosphonate | Medicine & Public Health | Osteonecrosis of the jaw | Oncology | Metastatic breast cancer | Bevacizumab | MULTIPLE-MYELOMA | RISK-FACTORS | EFFICACY | BONE METASTASES | PREVENTION | ONJ | ONCOLOGY | PROSTATE-CANCER | EXPERIENCE | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Osteonecrosis - epidemiology | Humans | Jaw Diseases - prevention & control | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Incidence | Jaw Diseases - chemically induced | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Female | Paclitaxel - administration & dosage | Angiogenesis Inhibitors - adverse effects | Diphosphonates - adverse effects | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Double-Blind Method | Jaw Diseases - epidemiology | Breast Neoplasms - drug therapy | Oral Hygiene | Drug Synergism | Breast Neoplasms - complications | Taxoids - administration & dosage | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Genes, erbB-2 | Aged | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Care and treatment | Analysis | Phosphonates | Clinical trials | Bones | Breast cancer | Angiogenesis inhibitors | Health aspects | Necrosis | Index Medicus
Journal Article
Journal Article
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 01/2019, Volume 31, Issue 1, pp. 35 - 42
PURPOSE OF REVIEWCurrent standard for HER2+ early breast cancer patients includes chemotherapy and trastuzumab for 1 year. The purpose of this article is to... 
CARDIAC SAFETY | MULTICENTER | FINAL ANALYSIS | breast cancer | FOLLOW-UP | dual blockade | OPEN-LABEL | PLUS TRASTUZUMAB | ADJUVANT TRASTUZUMAB | FREE CHEMOTHERAPY REGIMENS | SINGLE-GROUP | ONCOLOGY | de-escalation | HER2 | NEOADJUVANT PERTUZUMAB | Care and treatment | Breast cancer | Genetic aspects | Research
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 9/2015, Volume 7, Issue 3, pp. 161 - 169
The phosphoinositide 3 kinase (PI3K)/Akt pathway is frequently aberrantly activated in breast cancer and, basing on preclinical data, leads to cell growth and... 
Medicine & Public Health | PIK3CA | PI3K | Oncology | Internal Medicine | Breast cancer | Predictive factor | Surgical Oncology | Estrogen
Journal Article
Journal Article
Journal Article
Breast Cancer Research, ISSN 1465-5411, 06/2018, Volume 20, Issue 1, pp. 62 - 62
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 7, pp. e0132496 - e0132496
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 6/2018, Volume 138, Issue 2, pp. 369 - 382
Journal Article